
|Videos|June 10, 2015
Effect of New Chronic Heart Failure Drug on Disease Management
Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, discusses how he thinks new chronic heart failure drugs could change heart failure management from a health-system pharmacist's perspective.
Advertisement
Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, discusses how he thinks new chronic heart failure drugs could change heart failure management from a health-system pharmacist's perspective.
This video was recorded at ASHP's Summer Meeting and Exposition in June 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























